MRC2
Basic information
Region (hg38): 17:62627670-62693597
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 73 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 73 | 1 | 2 |
Variants in MRC2
This is a list of pathogenic ClinVar variants found in the MRC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-62627866-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
17-62664642-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
17-62664770-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
17-62664838-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
17-62664839-G-A | not specified | Uncertain significance (Mar 25, 2022) | ||
17-62664860-C-T | not specified | Uncertain significance (May 18, 2023) | ||
17-62664892-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
17-62664893-G-C | Benign (Feb 20, 2018) | |||
17-62666126-A-G | not specified | Uncertain significance (Aug 16, 2021) | ||
17-62666181-G-C | not specified | Uncertain significance (Apr 08, 2022) | ||
17-62666204-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
17-62666222-C-A | not specified | Uncertain significance (May 30, 2024) | ||
17-62666231-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
17-62666232-G-A | not specified | Uncertain significance (Mar 05, 2024) | ||
17-62666244-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
17-62666526-A-G | not specified | Uncertain significance (Jun 18, 2024) | ||
17-62666533-C-T | not specified | Uncertain significance (May 24, 2023) | ||
17-62666568-G-C | not specified | Uncertain significance (Jun 02, 2024) | ||
17-62666590-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
17-62666869-T-G | not specified | Uncertain significance (Jun 21, 2022) | ||
17-62671666-A-C | not specified | Uncertain significance (Jan 04, 2024) | ||
17-62671732-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
17-62671816-A-C | not specified | Uncertain significance (Oct 17, 2023) | ||
17-62672151-C-T | not specified | Uncertain significance (Jan 27, 2022) | ||
17-62674110-C-G | not specified | Uncertain significance (Dec 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRC2 | protein_coding | protein_coding | ENST00000303375 | 30 | 66197 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.675 | 0.325 | 125705 | 0 | 43 | 125748 | 0.000171 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.73 | 661 | 890 | 0.743 | 0.0000578 | 9603 |
Missense in Polyphen | 179 | 322.98 | 0.55421 | 3614 | ||
Synonymous | 1.23 | 343 | 373 | 0.919 | 0.0000262 | 2798 |
Loss of Function | 6.77 | 19 | 87.3 | 0.218 | 0.00000427 | 876 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000491 | 0.000490 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.000379 | 0.000370 |
European (Non-Finnish) | 0.000128 | 0.000114 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.000200 | 0.000196 |
Other | 0.000499 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis. May be involved in plasminogen activation system controlling the extracellular level of PLAUR/PLAU, and thus may regulate protease activity at the cell surface. May contribute to cellular uptake, remodeling and degradation of extracellular collagen matrices. May play a role during cancer progression as well as in other chronic tissue destructive diseases acting on collagen turnover. May participate in remodeling of extracellular matrix cooperating with the matrix metalloproteinases (MMPs). {ECO:0000269|PubMed:10683150, ECO:0000269|PubMed:12972549}.;
- Pathway
- Phagosome - Homo sapiens (human);Tuberculosis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Immune System;Adaptive Immune System;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Cross-presentation of soluble exogenous antigens (endosomes)
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.532
- rvis_EVS
- -1.16
- rvis_percentile_EVS
- 6.09
Haploinsufficiency Scores
- pHI
- 0.683
- hipred
- Y
- hipred_score
- 0.693
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.509
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrc2
- Phenotype
- cellular phenotype; immune system phenotype; normal phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- osteoblast differentiation;endocytosis;collagen catabolic process
- Cellular component
- focal adhesion;membrane;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;collagen binding;carbohydrate binding